Literature DB >> 16564295

Successful endothelialization of porcine glutaraldehyde-fixed aortic valves in a heterotopic sheep model.

Helmut Gulbins1, Anita Pritisanac, Korbinian Pieper, Angelika Goldemund, Bruno M Meiser, Bruno Reichart, Sabine Daebritz.   

Abstract

PURPOSE: The purpose of our study was to evaluate the stability of an artificially seeded endothelial cell layer on porcine aortic prostheses under in vivo conditions in the arterial system. DESCRIPTION: Ten female sheep were divided into two groups. Animals of the study group (n = 7) had dissection of their right external jugular vein for cell harvesting. Myofibroblasts and endothelial cells were labelled with PKH-26, seeded onto pretreated (10% citric acid) porcine glutaraldehyde-fixed aortic valves (Freestyle, Medtronic Inc, Duesseldorf, Germany), and the valves were implanted into the descending aorta. Controls (n = 3) received pretreated but unseeded valves. A shunt between the aortic arch and the left atrial appendage ensured systolic or diastolic leaflet motions, or both, that were documented by sonography. After 3 months the valves were explanted. Specimens for scanning electron microscopy and immunohistochemical staining were taken prior to implantation and after explantation. EVALUATION: A neointimal proliferation was detected in the control group. No endothelial cells were found on the leaflets and the sinuses, but erythrocytes and thrombocytes were seen entrapped within the collagen fibers. Thrombus formation was documented macroscopically and histologically on the leaflets and the sinuses. In the study group a confluent endothelial cell layer was documented on the walls and leaflets. Neither neointimal proliferation nor any clots were seen. Some cells were still labelled positively indicating their origin from the initial cell seeding. No dilatation of any prosthesis was observed, but all valves showed slight thickening of the leaflets.
CONCLUSIONS: The artificially seeded endothelial cell layers remained stable under in vivo conditions in the arterial system. Biocompatibility of the prostheses seemed to be improved by reduction of thrombogenicity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16564295     DOI: 10.1016/j.athoracsur.2005.11.011

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  4 in total

1.  Optimizing Glutaraldehyde-Fixed Tissue Heart Valves with Chondroitin Sulfate Hydrogel for Endothelialization and Shielding against Deterioration.

Authors:  Mario Lopez-Moya; Pedro Melgar-Lesmes; Kumaran Kolandaivelu; Jose María de la Torre Hernández; Elazer R Edelman; Mercedes Balcells
Journal:  Biomacromolecules       Date:  2018-03-20       Impact factor: 6.988

2.  In vivo evaluation of an in-body, tissue-engineered, completely autologous valved conduit (biovalve type VI) as an aortic valve in a goat model.

Authors:  Yoshiaki Takewa; Masashi Yamanami; Yuichiro Kishimoto; Mamoru Arakawa; Keiichi Kanda; Yuichi Matsui; Tomonori Oie; Hatsue Ishibashi-Ueda; Tsutomu Tajikawa; Kenkichi Ohba; Hitoshi Yaku; Yoshiyuki Taenaka; Eisuke Tatsumi; Yasuhide Nakayama
Journal:  J Artif Organs       Date:  2012-12-20       Impact factor: 1.731

3.  Form Follows Function: Advances in Trilayered Structure Replication for Aortic Heart Valve Tissue Engineering.

Authors:  Dan T Simionescu; Joseph Chen; Michael Jaeggli; Bo Wang; Jun Liao
Journal:  J Healthc Eng       Date:  2012-06       Impact factor: 2.682

4.  Fabrication of aortic bioprosthesis by decellularization, fibrin glue coating and re-endothelization: a cell scaffold approach.

Authors:  Sonal Walawalkar; Shahdab Almelkar
Journal:  Prog Biomater       Date:  2019-10-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.